Symbol="SRPT"
AssetType="Common Stock"
Name="Sarepta Therapeutics Inc"
Description="Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="873303"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="10153209000"
EBITDA="-539008000"
PERatio="None"
PEGRatio="159.25"
BookValue="7.65"
DividendPerShare="0"
DividendYield="0"
EPS="-12.33"
RevenuePerShareTTM="11.11"
ProfitMargin="-1.143"
OperatingMarginTTM="-0.596"
ReturnOnAssetsTTM="-0.119"
ReturnOnEquityTTM="-1.421"
RevenueTTM="975683000"
GrossProfitTTM="-78066000"
DilutedEPSTTM="-12.33"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.202"
AnalystTargetPrice="175.21"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="12.49"
PriceToBookRatio="25.74"
EVToRevenue="12.09"
EVToEBITDA="-17.47"
Beta="0.99"
num_52WeekHigh="159.89"
num_52WeekLow="77.39"
num_50DayMovingAverage="126.61"
num_200DayMovingAverage="123.81"
SharesOutstanding="93149000"
DividendDate="None"
ExDividendDate="None"
symbol="SRPT"
open="110.00"
high="111.05"
low="108.59"
price="109.00"
volume="842440.00"
latest_trading_day="2023-07-07"
previous_close="110.00"
change="-1.00"
change_percent="-0.9091%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="19"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="81"
Volume_recent_avg="1587763"
Change_recent_avg="-0.08"
Delta_recent_avg="4.76"
Variance_recent_avg="2.38"
Change_ratio_recent_avg="-0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_10"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="81"
Aroon_momentum_negative="19"
image_negative_thumbnail_id_1="130"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0046.jpeg"
image_negative_thumbnail_id_2="146"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0030.jpeg"
image_neutral_thumbnail_id_1="529"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="999"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0161.jpeg"
image_positive_thumbnail_id_2="626"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0082.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
